Healthcare

Pegfilgrastim is developed by PEGylating the recombinant human granulocyte colony-stimulating factor (G-CSF) analogue, filgrastim. Pegfilgrastim was first launched by Amgen Inc. as Neulasta in 2002. Later, several biosimilars of pegfilgrastim …

Pegfilgrastim Biosimilar Size Market Is Expected To Witness An Upswing In The Future Read More

Niacin and Niacinamide are revolutionary supplements that have gained traction for their ability to cut squamous cell and basal cell skin cancers by nearly 20% giving unprecedented rigor to its …

Global Niacin And Niacinamide Market Is Projected To Witness A Cagr Of 5% In Value By 2027 Read More

The surgical sutures market revenue totalled US$ 3.9 Bn for 2018, according to Fact.MR The global Surgical Sutures Market is expected to reach US$ 4.4 Bn. by 2021 and it is projected to …

Global Surgical Sutures Market Is Anticipated To Add 1.5x Value By 2031 Read More

The global vaccine management solutions market was valued at over $140 million in 2019 and is expected to reach $590 million by 2030. The spread of COVID-19 has increased the demand …

Global Vaccine Management Solution Market Is Projected To Surge At An Impressive CAGR Of Over 17% Through 2030 Read More

As per a revised analysis by Fact.MR, a market research and competitive intelligence provider, the global medical case management service market is predicted to rise at a CAGR of 3.2% …

Medical Case Management Service Industry To Expand At A Stagnant CAGR Of Around 3.2% Over The Decade Read More

According to Fact.MR, the global market for prostate cancer diagnostics was valued at around US$ 3 Bn in 2020 and is projected to expand at a staggering CAGR of over 10% through 2031. The …

Global Prostate Cancer Market Is Expected To Surpass US$ 8 Billion By 2031 Read More

The Fact.MR new report on the market survey of Melanoma Cancer Diagnostics gives estimations of the Size of Melanoma Cancer Diagnostics Market and the overall Melanoma Cancer Diagnostics Market share …

Melanoma Cancer Diagnostics Market Is Expected To Register CAGR Of 4.7% By 2028 Read More

Globally, the prevalence of cancer is increasing, resulting in rising demand for early diagnosis and treatment. According to the National Cancer Institutes, as of January 2019, there were an estimated …

Rising Prevalence Of Cancer Is Expected To Create Significant Demand For Multiphoton Microscopy Across The Globe Read More

As per Fact.MR, a market research and competitive intelligence provider, the global OTC cough, cold, and allergy medicine market is anticipated to top US$ 60 Bn by 2031, progressing at …

Increasing Worldwide Aging Population Are Expected To Drive Demand For OTC Medicines Read More